The FDA is taking a fresh look at how to improve its gold standard for product review and consumer protection in 2019. It is therefore important that you know what to expect from the FDA in the second year of the Trump administration, and how this will likely impact your drug and medical device products. Doing so will not only prepare you in advance for the forthcoming changes, but also keep you one step ahead of the competition.
Learn what to expect from the FDA in 2019 in this webinar by industry expert Norma Skolnik. Skolnik will provide special insight on topics you may not find elsewhere on the market – such as the likely trends and changes to be expected from the FDA in the coming year; what new legislation will impact the pharmaceutical and consumer healthcare industry in 2019, and how the new FDA initiatives will impact the U.S. opioid crisis.
After attending this webinar, you will know the likely changes, trends, and legislations to expect from the FDA in 2019 – including how they will impact your industry. You will also be better informed about the FDA’s new steps in confronting the opioid crisis.
This webinar will bring you up to speed with key areas, such as:
Who Should Attend
Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.
Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as Director of Regulatory Affairs for the Americas for Cadbury Adams. Prior to that, she was Director of Regulatory Affairs for the Adams Division of Pfizer and Associate Director of Regulatory Affairs for the Warner-Lambert company. She also served as Director of Regulatory Affairs for Lederle Consumer Healthcare and...
More Events By The Speaker